XML 33 R22.htm IDEA: XBRL DOCUMENT v3.8.0.1
Revenue (Tables)
3 Months Ended
Mar. 31, 2018
Schedule of Disaggregates Revenue by Major Source

The following table disaggregates our revenue by major source for the three month periods ended March 31, 2018 and 2017 (in thousands):

 

2018

Acute Care

 

 

Behavioral Health

 

 

Other

 

 

Total

 

Medicare

$

342,718

 

 

24

%

 

$

142,527

 

 

12

%

 

 

 

 

 

$

485,245

 

 

18

%

Managed Medicare

 

176,957

 

 

12

%

 

 

44,995

 

 

4

%

 

 

 

 

 

 

221,952

 

 

8

%

Medicaid

 

105,966

 

 

7

%

 

 

177,336

 

 

14

%

 

 

 

 

 

 

283,302

 

 

11

%

Managed Medicaid

 

111,277

 

 

8

%

 

 

230,776

 

 

19

%

 

 

 

 

 

 

342,053

 

 

13

%

Managed Care (HMO and PPOs)

 

497,780

 

 

34

%

 

 

358,062

 

 

29

%

 

 

 

 

 

 

855,842

 

 

32

%

UK Revenue

 

0

 

 

0

%

 

 

114,741

 

 

9

%

 

 

 

 

 

 

114,741

 

 

4

%

Other patient revenue

 

112,570

 

 

8

%

 

 

116,985

 

 

9

%

 

 

 

 

 

 

229,555

 

 

9

%

Other non-patient revenue

 

98,364

 

 

7

%

 

 

52,574

 

 

4

%

 

 

3,888

 

 

 

154,826

 

 

6

%

Total Net Revenue

$

1,445,632

 

 

100

%

 

$

1,237,996

 

 

100

%

 

$

3,888

 

 

 

2,687,516

 

 

100

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2017

Acute Care

 

 

Behavioral Health

 

 

Other

 

 

Total

 

Medicare

$

316,385

 

 

23

%

 

$

146,645

 

 

12

%

 

 

 

 

 

$

463,030

 

 

18

%

Managed Medicare

 

144,047

 

 

10

%

 

 

36,674

 

 

3

%

 

 

 

 

 

 

180,721

 

 

7

%

Medicaid

 

92,657

 

 

7

%

 

 

180,949

 

 

15

%

 

 

 

 

 

 

273,606

 

 

10

%

Managed Medicaid

 

114,552

 

 

8

%

 

 

217,645

 

 

18

%

 

 

 

 

 

 

332,197

 

 

13

%

Managed Care (HMO and PPOs)

 

477,266

 

 

34

%

 

 

355,338

 

 

29

%

 

 

 

 

 

 

832,604

 

 

32

%

UK Revenue

 

0

 

 

0

%

 

 

100,022

 

 

8

%

 

 

 

 

 

 

100,022

 

 

4

%

Other patient revenue

 

123,374

 

 

9

%

 

 

124,798

 

 

10

%

 

 

 

 

 

 

248,172

 

 

9

%

Other non-patient revenue

 

121,266

 

 

9

%

 

 

56,051

 

 

5

%

 

 

5,189

 

 

 

182,506

 

 

7

%

Total Net Revenue

$

1,389,547

 

 

100

%

 

$

1,218,122

 

 

100

%

 

$

5,189

 

 

 

2,612,858

 

 

100

%

 

ASU 2014-09  
Schedule of Impact of Adoption on Condensed Consolidated Income Statement

On January 1, 2018, we adopted the new accounting standard using the modified retrospective method. The information in comparative periods have not been restated and continues to be reported under the accounting standards in effect for those periods. In accordance with the new revenue standard requirements, the disclosure of the impact of adoption on our condensed consolidated income statement was as follows (in thousands):

 

 

 

 

 

 

Balances

 

 

 

 

 

 

 

 

 

 

Without

 

 

 

 

 

 

As

 

 

Adoption

 

 

Effect

 

2018

Reported

 

 

ASC 606

 

 

of Change

 

Net Revenue before provision for doubtful accounts

 

 

 

 

$

2,931,527

 

 

 

 

 

Less: Provision for doubtful accounts

 

 

 

 

 

246,543

 

 

 

 

 

Net Revenues

$

2,687,516

 

 

$

2,684,984

 

 

$

2,532

 

 

 

 

 

 

 

 

 

 

 

 

 

Other operating expenses

$

620,819

 

 

$

618,287

 

 

$

2,532